News
Hosted on MSN9mon
HIV breakthrough: drug trial shows injection twice a year is 100 per cent effective against infectionSecondly, the trial also tested whether Descovy F/TAF, a newer daily pill ... t keep pills without facing stigma or violence, an injection just twice a year is the option that could keep her ...
The FDA has approved Gilead’s combination drug Descovy for HIV prophylaxis in the US, offering a way of cutting the risk of sexually acquired infection with an improved safety profile compared ...
Gilead’s Descovy got a green light from an FDA advisory committee for HIV pre-exposure prophylaxis (PrEP) yesterday – but as expected its use in women was a point of contention. Descovy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results